Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

That is the advice from two survivors who want to raise awareness of the signs of testicular and prostate cancer. Aaron ...

According to the 2019 National Cancer Registry the lifetime risk for prostate cancer in South Africa is 1 in every 15 man. Prostate cancer is the most common cancer in men globally and is showing a ...

The global hormone-sensitive advanced prostate cancer treatment market is projected to achieve a valuation of USD 12.44 ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

October was Breast Cancer Awareness Month. According to the CDC, one in eight women will contract breast cancer. It is the ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

In this article, Dr. Himesh Gandhi shared valuable knowledge on prostate cancer and importance of an early detection.

Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...